FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200287939> ?p ?o ?g. }

• W4200287939 endingPage "e12506" @default.
• W4200287939 startingPage "e12506" @default.
• W4200287939 abstract "Spindle and kinetochore associated complex subunit 3 (SKA3) plays an important role in tumorigenesis and the progression of various tumors. But the relationship between SKA3 and early breast cancer remains unclear. The study aimed to explore the prognostic significance of SKA3 in breast cancer.In the study, SKA3 expression was initially assessed using the Oncomine database and The Cancer Genome Atlas database (TCGA). Then, we presented validation results for RT-qPCR (quantitative reverse transcription PCR) and ELISA (enzyme-linked immunosorbent assay). The relationship between clinical characteristics and SKA3 expression was assessed by Chi-square test and Fisher's exact test. Kaplan-Meier method and Cox regression analysis were conducted to evaluate the prognostic value of SKA3. Gene set enrichment analysis (GSEA) was performed to screen biological pathways using the TCGA dataset. Besides, single sample gene set enrichment analysis (ssGSEA) was utilized to identify immune infiltration cells about SKA3.SKA3 mRNA was expressed at high levels in breast cancer tissues compared with normal tissues. Chi-square test and Fisher's exact test showed SKA3 expression was related to age, tumor (T) classification, node (N) classification, tumor-node-metastasis (TNM) stage, estrogen receptor (ER), progesterone receptor (PR), molecular subtype, and race. RT-qPCR results showed that SKA3 expression was overexpressed in ER, PR status, and molecular subtype in Chinese people. Kaplan-Meier curves implicated that high SKA3 expression was related to a poor prognosis in female early breast cancer patients. Cox regression models showed that high SKA3 expression could be used as an independent risk factor for female early breast cancer. Four signaling pathways were enriched in the high SKA3 expression group, including mTORC1 signaling pathway, MYC targets v1, mitotic spindle, estrogen response early. Besides, the SKA3 expression level was associate with infiltrating levels of activated CD4 T cells and eosinophils in breast cancer.High SKA3 expression correlates with poor prognosis and immune infiltrates in breast cancer. SKA3 may become a biomarker for the prognosis of breast cancer." @default.
• W4200287939 created "2021-12-31" @default.
• W4200287939 creator A5029487532 @default.
• W4200287939 creator A5032131879 @default.
• W4200287939 creator A5046230243 @default.
• W4200287939 creator A5054950396 @default.
• W4200287939 creator A5059951107 @default.
• W4200287939 creator A5072480558 @default.
• W4200287939 creator A5073987992 @default.
• W4200287939 creator A5086099209 @default.
• W4200287939 creator A5088347398 @default.
• W4200287939 date "2021-12-13" @default.
• W4200287939 modified "2023-09-23" @default.
• W4200287939 title "Overexpression of SKA3 correlates with poor prognosis in female early breast cancer" @default.
• W4200287939 cites W1810028515 @default.
• W4200287939 cites W1835915349 @default.
• W4200287939 cites W1883415090 @default.
• W4200287939 cites W1977918192 @default.
• W4200287939 cites W1988902633 @default.
• W4200287939 cites W1998667229 @default.
• W4200287939 cites W2025616449 @default.
• W4200287939 cites W2030564732 @default.
• W4200287939 cites W2040235797 @default.
• W4200287939 cites W2069747769 @default.
• W4200287939 cites W2071181338 @default.
• W4200287939 cites W2084502831 @default.
• W4200287939 cites W2105436095 @default.
• W4200287939 cites W2107277218 @default.
• W4200287939 cites W2114104545 @default.
• W4200287939 cites W2130410032 @default.
• W4200287939 cites W2135914135 @default.
• W4200287939 cites W2159675211 @default.
• W4200287939 cites W2159707944 @default.
• W4200287939 cites W2192080449 @default.
• W4200287939 cites W2263099662 @default.
• W4200287939 cites W2295060570 @default.
• W4200287939 cites W2296450909 @default.
• W4200287939 cites W2332912393 @default.
• W4200287939 cites W2442447928 @default.
• W4200287939 cites W2494289731 @default.
• W4200287939 cites W2525429999 @default.
• W4200287939 cites W2537623931 @default.
• W4200287939 cites W2611131266 @default.
• W4200287939 cites W2794286377 @default.
• W4200287939 cites W2805552648 @default.
• W4200287939 cites W2889027345 @default.
• W4200287939 cites W2889646458 @default.
• W4200287939 cites W2891610296 @default.
• W4200287939 cites W2899175565 @default.
• W4200287939 cites W2901098315 @default.
• W4200287939 cites W2903244362 @default.
• W4200287939 cites W2903776113 @default.
• W4200287939 cites W2916953629 @default.
• W4200287939 cites W2949273159 @default.
• W4200287939 cites W2951071083 @default.
• W4200287939 cites W2971660841 @default.
• W4200287939 cites W2991056438 @default.
• W4200287939 cites W2993388453 @default.
• W4200287939 cites W2999504898 @default.
• W4200287939 cites W3008097514 @default.
• W4200287939 cites W3012189065 @default.
• W4200287939 cites W3012532848 @default.
• W4200287939 cites W3024650334 @default.
• W4200287939 cites W3025541946 @default.
• W4200287939 cites W3097629227 @default.
• W4200287939 cites W3108044685 @default.
• W4200287939 cites W3120159063 @default.
• W4200287939 doi "https://doi.org/10.7717/peerj.12506" @default.
• W4200287939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34993016" @default.
• W4200287939 hasPublicationYear "2021" @default.
• W4200287939 type Work @default.
• W4200287939 citedByCount "1" @default.
• W4200287939 countsByYear W42002879392022 @default.
• W4200287939 crossrefType "journal-article" @default.
• W4200287939 hasAuthorship W4200287939A5029487532 @default.
• W4200287939 hasAuthorship W4200287939A5032131879 @default.
• W4200287939 hasAuthorship W4200287939A5046230243 @default.
• W4200287939 hasAuthorship W4200287939A5054950396 @default.
• W4200287939 hasAuthorship W4200287939A5059951107 @default.
• W4200287939 hasAuthorship W4200287939A5072480558 @default.
• W4200287939 hasAuthorship W4200287939A5073987992 @default.
• W4200287939 hasAuthorship W4200287939A5086099209 @default.
• W4200287939 hasAuthorship W4200287939A5088347398 @default.
• W4200287939 hasBestOaLocation W42002879393 @default.
• W4200287939 hasConcept C10515644 @default.
• W4200287939 hasConcept C121608353 @default.
• W4200287939 hasConcept C126322002 @default.
• W4200287939 hasConcept C143998085 @default.
• W4200287939 hasConcept C191093355 @default.
• W4200287939 hasConcept C502942594 @default.
• W4200287939 hasConcept C50382708 @default.
• W4200287939 hasConcept C530470458 @default.
• W4200287939 hasConcept C555283112 @default.
• W4200287939 hasConcept C71924100 @default.
• W4200287939 hasConcept C84606932 @default.
• W4200287939 hasConcept C86803240 @default.
• W4200287939 hasConcept C98717036 @default.
• W4200287939 hasConceptScore W4200287939C10515644 @default.

• next